Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX intravesical instillation in OAB with urinary incontinence
NCT03320850Phase 2Completed
- Sponsor
- Allergan
- Start
- Oct 2017
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of onabotulinumtoxinA in overactive bladder (OAB), urinary incontinence (UI), sponsored by Allergan. Started Oct 2017; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT03320850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320850.